- Home
- COLD vs RNA Comparison
COLD vs RNA Comparison
Compare COLD & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COLD | RNA |
|---|---|---|
| Founded | 1903 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 4.0B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | COLD | RNA |
|---|---|---|
| Price | $10.75 | $71.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 20 |
| Target Price | $15.93 | ★ $69.26 |
| AVG Volume (30 Days) | ★ 7.4M | 2.9M |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | ★ 8.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,607,407,000.00 | $20,868,000.00 |
| Revenue This Year | N/A | $64.11 |
| Revenue Next Year | N/A | $37.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 106.27 |
| 52 Week Low | $10.10 | $21.51 |
| 52 Week High | $23.62 | $71.79 |
Technical Indicators
Market Signals| Indicator | COLD | RNA |
|---|---|---|
| Relative Strength Index (RSI) | 40.25 | 77.56 |
| Support Level | $10.62 | $71.42 |
| Resistance Level | $11.33 | $71.76 |
| Average True Range (ATR) | 0.40 | 0.41 |
| MACD | 0.13 | -0.73 |
| Stochastic Oscillator | 65.85 | 88.32 |
Price Performance
Historical ComparisonAbout COLD Americold Realty Trust Inc.
Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 239 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.